DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 111 participants.

Also called NCT01614366

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 111 participants (enrolled count) (from the registry)
Sponsor
TSH Biopharm Corporation Limited (from the registry)
Registry
  • NCT NCT01614366
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01614366. Non-randomized; single masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension
Condition
Hypertension
Intervention (Drug)
AM 5 + DM 0
Intervention (Drug)
AM 5 + DM 2.5
Intervention (Drug)
AM 5 + DM 7.5
Intervention (Drug)
AM 5 + DM 30
Lead sponsor
TSH Biopharm Corporation Limited (class: industry)

Record details

Record id
cardio:ct-nct01614366
Content hash
13f7957ec415333028cc6e2b2269b166c70e852ed06d30008c4f9959ac8e05de